These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 19760349

  • 1. Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy.
    Voigt A, Bartel K, Egerer K, Trimpert C, Feist E, Gericke C, Kandolf R, Klingel K, Kuckelkorn U, Stangl K, Felix SB, Baumann G, Kloetzel PM, Staudt A.
    Basic Res Cardiol; 2010 Jan; 105(1):9-18. PubMed ID: 19760349
    [Abstract] [Full Text] [Related]

  • 2. Lack of evidence for a pathogenic role of proteasome-directed autoimmunity in dilated cardiomyopathy.
    Voigt A, Trimpert C, Bartel K, Egerer K, Kuckelkorn U, Feist E, Gericke C, Klingel K, Kandolf R, Felix SB, Baumann G, Kloetzel PM, Stangl K, Staudt A.
    Basic Res Cardiol; 2010 Jul; 105(4):557-67. PubMed ID: 20336303
    [Abstract] [Full Text] [Related]

  • 3. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B, Richter A, Sandmöller A, Portig I, Pankuweit S, BMBF-Heart Failure Network.
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [Abstract] [Full Text] [Related]

  • 4. Anti-heart autoantibodies in familial dilated cardiomyopathy.
    Caforio AL, Vinci A, Iliceto S.
    Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
    [Abstract] [Full Text] [Related]

  • 5. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
    Caforio AL, Bonifacio E, Keeling PJ, Grazzini M, Schiaffino S, Bottazzo GF, McKenna WJ.
    G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
    [Abstract] [Full Text] [Related]

  • 6. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S.
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [Abstract] [Full Text] [Related]

  • 7. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
    Landsberger M, Staudt A, Choudhury S, Trimpert C, Herda LR, Klingel K, Kandolf R, Schultheiss HP, Kroemer HK, Völker U, Felix SB.
    Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
    Wang Z, Liao Y, Dong J, Li S, Wang J, Fu ML.
    Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
    [Abstract] [Full Text] [Related]

  • 9. Autoimmunity against M₂muscarinic acetylcholine receptor induces myocarditis and leads to a dilated cardiomyopathy-like phenotype.
    Yoshizawa A, Nagai S, Baba Y, Yamada T, Matsui M, Tanaka H, Miyoshi S, Amagai M, Yoshikawa T, Fukuda K, Ogawa S, Koyasu S.
    Eur J Immunol; 2012 May; 42(5):1152-63. PubMed ID: 22328321
    [Abstract] [Full Text] [Related]

  • 10. Inflammation in dilated cardiomyopathy.
    Pankuweit S, Ruppert V, Maisch B.
    Herz; 2004 Dec; 29(8):788-93. PubMed ID: 15599676
    [Abstract] [Full Text] [Related]

  • 11. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
    Blyszczuk P, Kania G, Dieterle T, Marty RR, Valaperti A, Berthonneche C, Pedrazzini T, Berger CT, Dirnhofer S, Matter CM, Penninger JM, Lüscher TF, Eriksson U.
    Circ Res; 2009 Oct 23; 105(9):912-20. PubMed ID: 19762681
    [Abstract] [Full Text] [Related]

  • 12. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
    Caforio AL, Bauce B, Boffa GM, De Cian F, Angelini A, Melacini P, Razzolini R, Fasoli G, Chioin R, Schiaffino S, Thiene G, Dalla Volta S.
    G Ital Cardiol; 1997 Feb 23; 27(2):106-12. PubMed ID: 9199945
    [Abstract] [Full Text] [Related]

  • 13. Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.
    Skurk C, Wittchen F, Suckau L, Witt H, Noutsias M, Fechner H, Schultheiss HP, Poller W.
    Eur Heart J; 2008 May 23; 29(9):1168-80. PubMed ID: 18390538
    [Abstract] [Full Text] [Related]

  • 14. Pathophysiology of cardiac inflammation: molecular mechanisms.
    Pankuweit S, Portig I, Maisch B.
    Herz; 2002 Nov 23; 27(7):669-76. PubMed ID: 12439638
    [Abstract] [Full Text] [Related]

  • 15. Enhanced expression and autoimmunity of recombination signal binding protein-jkappa in human dilated cardiomyopathy.
    Nickenig G, Wolff M, Stäblein A, Pfister H, Böhm M.
    Biochem Biophys Res Commun; 1999 Dec 20; 266(2):432-6. PubMed ID: 10600520
    [Abstract] [Full Text] [Related]

  • 16. Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy.
    Shmilovich H, Danon A, Binah O, Roth A, Chen G, Wexler D, Keren G, George J.
    Int J Cardiol; 2007 Apr 25; 117(2):198-203. PubMed ID: 16887211
    [Abstract] [Full Text] [Related]

  • 17. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
    Rahnefeld A, Klingel K, Schuermann A, Diny NL, Althof N, Lindner A, Bleienheuft P, Savvatis K, Respondek D, Opitz E, Ketscher L, Sauter M, Seifert U, Tschöpe C, Poller W, Knobeloch KP, Voigt A.
    Circulation; 2014 Oct 28; 130(18):1589-600. PubMed ID: 25165091
    [Abstract] [Full Text] [Related]

  • 18. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects.
    Felix SB, Staudt A.
    Int J Cardiol; 2006 Sep 10; 112(1):30-3. PubMed ID: 16860418
    [Abstract] [Full Text] [Related]

  • 19. [The pathogenesis of dilated cardiomyopathy: current progress].
    Mestroni L, Giacca M, Severini GM, Camerini F.
    G Ital Cardiol; 1992 Jan 10; 22(1):53-62. PubMed ID: 1624069
    [Abstract] [Full Text] [Related]

  • 20. Highly variable expression of virus receptors in the human cardiovascular system. Implications for cardiotropic viral infections and gene therapy.
    Poller W, Fechner H, Noutsias M, Tschoepe C, Schultheiss HP.
    Z Kardiol; 2002 Dec 10; 91(12):978-91. PubMed ID: 12490988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.